Dosing Regimen Design Infusion regimen.

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

CHAPTER 4 INTRAVENOUS INFUSION.
First, zero, pseudo-zero order elimination Clearance
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Pharmacy 732 Winter Instructors William HaytonPharmaceutics James CoylePPAD Cari BrackettPPAD Kristin LugoPPAD Juhyun KimPharmaceutics.
HOW DO I DESIGN AND ADJUST A DOSAGE REGIMEN?. PHARMACOKINETICS WHAT IS THE BEST WAY TO GAIN AN UNDERSTANDING OF HOW TO DESIGN AND ADJUST A DOSAGE REGIMEN?
Pharmacokinetics of Drug Absorption
Pharmacokinetics Questions
Nonlinear pharmacokinetics
1 Intravenous Infusion Equations Some drugs are administered using a continuous intravenous infusion, and if the infusion is discontinued the serum concentration/time.
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
Index of Simulations 1-Compartment, IV bolus 1-Compartment, IV infusion: Steady- State1-Compartment, IV infusion: Steady- State 1-Compartment, IV infusion:
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Toxicokinetic Calculations
Gokaraju Rangaraju College of Pharmacy
Module 2 # 3 Pharmacokinetics how to make sense of the previous lesson or why do I have to learn this stuff?
INTRAVENOUS INFUSION.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
University of Jordan-Faculty of Pharmacy
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
10/13/20151Prof. Mazen Qato. OBJECTIVES 10/13/2015Prof. Mazen Qato2.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Multiple Dosing: Intermittent or multiple dose regimen
1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.
Area under the plasma concentration time curve. IMPORTANCE OF AUC Pharmacokinetics - measurement of bioavaibility absolute, relative Biopharmaceutics.
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Multiple dosing: intravenous bolus administration
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
Continuous intravenous infusion (one-compartment model)
BIOPHARMACEUTICS.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Phoenix WinNonLin Assignment Due Today Access Phoenix remotely.
Nonlinear Pharmacokinetics
Prof. Dr. Henny Lucida, Apt
Pharmacokinetic Models
Clinical Pharmacokinetic Equations and Calculations
Lecture 2 Clearance, maintenance dose and AUC
The General Concepts of Pharmacokinetics and Pharmacodynamics
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
Pharmacokinetics 3rd Lecture
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
MULTIPLE DOSAGE REGIMEN
Pharmacokinetics Pharmacokinetic techniques attempt to mathematically define the time course for the drug in the body by assaying for drug and metabolites.
Pharmacokinetics Tutoring
Chapter 7 COMPARTMENT MODELS
PHARMACOKINETICS Allie punke
Controls and Functions
Pharmacokinetics Tutoring
Dosing Regimen Concepts: 2-C, MM, Individualization principles
Lab-3 practical pharmacology
PHARMACOKINETICS Allie punke
Clinical Pharmacokinetics
Clinical Pharmacokinetics
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring chapter 1 part 1
Multiple ORAL Dosing Objectives
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Presentation transcript:

Dosing Regimen Design Infusion regimen

Why is a dosing regimen necessary? To replace the drug that the body eliminates. How can drug be replaced? Continuously or intermittently.

Continuous Input Learning Objectives input rate to achieve a desired plasma concentration. kinetics of accumulation; i.e., how long to steady state. loading dose. determination of CL, V, KE and t1/2.

Examples of continuous input i.v. drip i.v. infusion transdermal patch sustained release oral dosage forms Ocusert Norplant

Kinetics of continuous input A = amount of drug in body Cp = plasma concentration Ko = input rate (amt/time) KE = elimination rate constant, (CL/V) dA/dt = rate in - rate out dA/dt = Ko - KEA A = V x Cp and KEV = CL dA/dt = Ko - CL•Cp v CL Ko dA/dt = 0 at a plateau Cp Rate In = Rate Out Ko = CL •Cp,ss Cp,ss = Ko/CL

Example: Diazepam Cp,t profile in young and old: DR adjustment? Ln Cp Time young old What’s different? Vss CL t1/2 fup [L/kg] [L/h/kg] [h] [%] 0.88 0.0174 44.5 2.49 1.39 0.0156 71.5 2.76 Herman and Wilkinson. Br. J. Clin. Pharmacol. 42:147,1996. #2919

Principles When infused at the same rate (one compartment model assumed): all drugs with the same half life will have the same steady-state amount of drug in the body. all drugs with the same clearance will have the same steady-state plasma concentration.

Accumulation Kinetics

Time to steady state 3.3 t1/2 is time to 90% of Cp,ss t = nt1/2 where n = no. of half lives that have passed

Example This drug has a V = 45 L and a CL = 12 L/h. What infusion rate is needed to achieve a Cp,ss of 25 mg/L? Ko = CL x Cp,ss = 12 L/h x 25 mg/L = 300 mg/h How long will it take to get to 90% of steady state? t1/2 = ln 2 V/CL = (0.693)(45)/(12) = 2.6 h t90% = 3.3 t1/2 = (3.3)(2.6) = 8.6 h How much drug is in the body at steady state? Ass = Cp,ssV = 45 L x 25 mg/L = 1,125 mg

Summary Cp,ss Ass Time to SS  Ko    CL   V

Diagram VP, VE, VR RE/I, fur, fup Ass Css Ko CL t90% V QH, fup, CLint,u GFR, etc.

Review With a constant rate of input, Ko Rate Out Rate In = _______ CL Rate In = Css x ___ Rate In = Ass x ___ KE All drugs with same CL will have same ____ Css All drugs with same t1/2 will have same ____ Ass

Post-Infusion Cp Profile

Post-Infusion Cp Profile

Changing to a new Cp,ss CL by 25% Ko by 25% V by 25% Cp Time

Bolus and Infusion A “loading dose” may be used to start at steady state immediately. Loading Dose = Ass = Ko/KE = CssV

Rowland and Tozer, Figure 6-5. p. 74

Time to Steady State 3.3 t1/2 is time to 90% of Cp,ss. When Cp,0 is 0, this is within ±10% of Cp,ss. When Cp,0 is  0, the time to ±10% of Cp,ss differs from the t90%. What is the appropriate endpoint for calculation of the time to steady state?

Calculation of time to ±10% Cp,ss Plasma concentration at any time after bolus + infusion: Given Cp,0 and Css, the time to reach any Cp can be calculated from:

Example Cp,0 = 500 mg/L and Css = 100 mg/L, how long does it take to reach 110 mg/L? (i.e., 110% of Css) (1/2)n = (100 – 110)/(100 – 500) = -10/-400 = 0.025 (n)[ln (0.5)] = ln (0.025) n = ln (0.025) / ln (0.5) = 5.32 half lives 140 mg/L What would be the Cp after 3.3 half lives?

Assessment of PK parameters 1. CL = Ko / Cp,ss Time Log (Cp,ss - Cp) -2.3 slope = KE 2. Get KE from the slope of a semilog plot of (Cp,ss – Cp) vs. t. 3. V = CL / KE